235 related articles for article (PubMed ID: 31874125)
1. Bioimpedance spectroscopy is not associated with a clinical diagnosis of breast cancer-related lymphedema.
Spitz JA; Chao AH; Peterson DM; Subramaniam V; Prakash S; Skoracki RJ
Lymphology; 2019; 52(3):134-142. PubMed ID: 31874125
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively.
Ridner SH; Dietrich MS; Spotanski K; Doersam JK; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder S; Shah C; Vicini F
Lymphat Res Biol; 2018 Oct; 16(5):435-441. PubMed ID: 30130147
[TBL] [Abstract][Full Text] [Related]
3. Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema: A Systematic Review.
Forte AJ; Huayllani MT; Boczar D; Ciudad P; Lu X; Kassis S; Parker AS; Moore PA; McLaughlin SA
Plast Surg Nurs; 2020; 40(2):86-90. PubMed ID: 32459756
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
Vicini F; Shah C; Whitworth P; Walker M; Shi J
Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
[No Abstract] [Full Text] [Related]
5. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema.
Seward C; Skolny M; Brunelle C; Asdourian M; Salama L; Taghian AG
J Surg Oncol; 2016 Oct; 114(5):537-542. PubMed ID: 27393376
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
Ridner SH; Dietrich MS; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder SM; Wagner J; Abramson V; Moore A; Shah C
Ann Surg Oncol; 2019 Oct; 26(10):3250-3259. PubMed ID: 31054038
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema.
Barrio AV; Eaton A; Frazier TG
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S370-5. PubMed ID: 26085222
[TBL] [Abstract][Full Text] [Related]
8. Comparison of perometry-based volumetric arm measurements and bioimpedance spectroscopy for early identification of lymphedema in a prospectively-screened cohort of breast cancer patients.
Gillespie TC; Roberts SA; Brunelle CL; Bucci LK; Bernstein MC; Daniell KM; Naoum GN; Miller CL; Taghian AG
Lymphology; 2021; 54(1):1-11. PubMed ID: 34506083
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.
Iyigun ZE; Duymaz T; Ilgun AS; Alco G; Ordu C; Sarsenov D; Aydin AE; Celebi FE; Izci F; Eralp Y; Ozmen V
Lymphat Res Biol; 2018 Feb; 16(1):28-35. PubMed ID: 28346852
[TBL] [Abstract][Full Text] [Related]
10. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
[TBL] [Abstract][Full Text] [Related]
11. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
[TBL] [Abstract][Full Text] [Related]
12. Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines.
Shah C; Vicini FA; Arthur D
Breast J; 2016 Nov; 22(6):645-650. PubMed ID: 27487985
[TBL] [Abstract][Full Text] [Related]
13. Lymphedema: Improving Screening and Treatment Among At-Risk Breast Cancer Survivors.
Reichart K
Clin J Oncol Nurs; 2017 Feb; 21(1):21-25. PubMed ID: 28107316
[TBL] [Abstract][Full Text] [Related]
14. Experimental and Analytical Comparisons of Tissue Dielectric Constant (TDC) and Bioimpedance Spectroscopy (BIS) in Assessment of Early Arm Lymphedema in Breast Cancer Patients after Axillary Surgery and Radiotherapy.
Lahtinen T; Seppälä J; Viren T; Johansson K
Lymphat Res Biol; 2015 Sep; 13(3):176-85. PubMed ID: 26305554
[TBL] [Abstract][Full Text] [Related]
15. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema.
Forte AJ; Huayllani MT; Boczar D; Avila FR; Kassis S; Ciudad P; Lu X; Moore PA; McLaughlin SA
Breast Dis; 2021; 40(2):85-93. PubMed ID: 33646139
[TBL] [Abstract][Full Text] [Related]
16. Segmental Bioimpedance Informs Diagnosis of Breast Cancer-Related Lymphedema.
Svensson BJ; Dylke ES; Ward LC; Kilbreath SL
Lymphat Res Biol; 2017 Dec; 15(4):349-355. PubMed ID: 28956701
[TBL] [Abstract][Full Text] [Related]
17. Bioimpedance spectroscopy in the detection of breast cancer-related lymphedema: An ounce of prevention.
Shah C
Breast J; 2019 Nov; 25(6):1323-1325. PubMed ID: 31518487
[No Abstract] [Full Text] [Related]
18. Intra- and Inter-Rater Reliability of Bioimpedance in the Evaluation of Lymphedema Secondary to Treatment of Breast Cancer.
Ferro AP; Ferreira VTK; Rezende MS; de Souza TR; Almeida AM; Guirro RRJ; Guirro ECO
Lymphat Res Biol; 2018 Jun; 16(3):282-286. PubMed ID: 29252100
[TBL] [Abstract][Full Text] [Related]
19. Staging Breast Cancer-Related Lymphedema with Bioimpedance Spectroscopy.
Ward LC; Koelmeyer LA; Moloney E
Lymphat Res Biol; 2022 Aug; 20(4):398-408. PubMed ID: 34756114
[No Abstract] [Full Text] [Related]
20. Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy.
Ward LC; Dylke E; Czerniec S; Isenring E; Kilbreath SL
Lymphat Res Biol; 2011 Mar; 9(1):47-51. PubMed ID: 21417767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
